Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial
Journal of Infection (2023) - Comments
doi: 10.1016/j.jinf.2022.12.003  issn: 0163-4453  pubmed: 36509358 

Suad Hannawi, Linda Saifeldin, Alaa Abuquta, Ahmad Alamadi, Sally A. Mahmoud, Jian Li, Yuanxin Chen, Liangzhi Xie